Barbara Levi
General Counsel bij UBS GROUP AG
Vermogen: 1 M $ op 31-03-2024
Profiel
Barbara Levi is currently the Director of the European General Counsel Association, a Member-Employees Board at King's College London, and the Group General Counsel at UBS AG and UBS Group AG.
Previously, she was the Group General Counsel at Rio Tinto Plc, the Chief Legal, Governance & Ethics Officer at Rio Tinto Ltd., the Global General Counsel at Sandoz International GmbH, and the Global Legal Head-Product Strategy at Novartis Pharma AG.
She received a graduate degree from the University of Milan and a graduate degree from Fordham University School of Law.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
UBS GROUP AG
0.00% | 31-12-2022 | 45 818 ( 0.00% ) | 1 M $ | 31-03-2024 |
Actieve functies van Barbara Levi
| Bedrijven | Functie | Begin |
|---|---|---|
| UBS GROUP AG | General Counsel | 01-11-2021 |
| UBS | General Counsel | 01-11-2021 |
| European General Counsel Association | Director/Board Member | - |
| King's College London | Corporate Officer/Principal | - |
Eerdere bekende functies van Barbara Levi
| Bedrijven | Functie | Einde |
|---|---|---|
| RIO TINTO PLC | Public Communications Contact | 25-10-2021 |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | General Counsel | 01-01-2019 |
| RIO TINTO GROUP | General Counsel | - |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | General Counsel | 01-01-2013 |
Opleiding van Barbara Levi
| University of Milan | Graduate Degree |
| Fordham University School of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| RIO TINTO PLC | Non-Energy Minerals |
| UBS GROUP AG | Finance |
| RIO TINTO GROUP | Non-Energy Minerals |
| Bedrijven in privébezit | 4 |
|---|---|
UBS AG
 UBS AG Investment ManagersFinance UBS AG engages in the provision of financial advisory solutions for private and institutional investors, intermediaries, and wealth management clients. The firm focuses on the areas of wealth and asset management, as well as investment banking. It offers retail investment products, global financing services, investment research, bespoke financing, traditional investments, as well as bonds and equities. The company was founded in 1862 and is headquartered in Zurich, Switzerland. | Finance |
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Health Technology |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
| European General Counsel Association |
